Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
01 February 2023
Closing Date:
06 March 2023
Location(s):
BE3 RÉGION WALLONNE (BE Belgium/BELGIQUE-BELGIË)
Description:
Framework agreement for the supply of Abiraterone, Trabectedin, Cabazitaxel, Fulvestrant and Rituximab IV

The purpose of the Framework Agreement is the supply of proprietary medicinal products, and more specifically Abiraterone, Trabectedin, Cabazitaxel, Fulvestrant, Rituximab IV in the form of 5 Lots

Abiratérone

Supply of Abiraterone

Trabectédine

Supply of Trabectedin

Cabazitaxel

Supply of Cabazitaxel

Fulvestrant

Supply of Fulvestrant

Rituximab IV

Fourniture de Rituximab IV

Download full details as .pdf
The Buyer:
Centrale de Négociation pour les Achats Hospitaliers
CPV Code(s):
33600000 - Pharmaceutical products